Professor Miles Fisher
Honorary Professor, University of Glasgow
Miles Fisher is a consultant diabetologist from Glasgow and an Honorary Professor at the University of Glasgow. Professor Fisher gained his medical degree from the University of Glasgow, UK and completed training in diabetes and endocrinology in the West of Scotland. Professor Fisher’s research interests are in cardiovascular aspects of diabetes, the pathophysiology of hypoglycaemia, and new treatments for diabetes. He received his MD in 1988 for his thesis on ‘Evidence for a diabetic cardiopathy.’ He was on the steering committee of the DIGAMI 2 study and was the Scottish co-ordinator. He was an events adjudicator for the HOPE, HOPE-2 and HOPE-TOO cardiovascular outcome trials, and for the albiglutide Harmony phase 3 development programme. He is currently a member of the Team Novo Nordisk Research Consortium studying professional cyclists with type 1 diabetes .He has been involved in guideline development for the Scottish Intercollegiate Guidelines Network (SIGN) and the European Society of Cardiology (ESC) and in guideline reviewing for SIGN, ESC, European Association for the Study of Diabetes (EASD) and NICE. He is the editor or co-editor of four books on heart disease in diabetes, three books on hypoglycaemia, and a book on SGLT2 inhibitors. He is the author or co-author of 49 book chapters, 84 original papers, 75 review articles, 36 leaders and editorials, 54 drug notes for Practical Diabetes and 15 drug notes for the British Journal of Cardiology.